Evidence Hub

Overview on spectrophotometric and chromatographic methods for estimation of atorvastatin calcium and sildenafil in bulk and in different dosage forms

International Journal of Biology Pharmacy and Allied Sciences, 2021

Abstract

Erectile dysfunction (ED) is a major health problem affecting 52% of men between 40 and 70 years.The association between ED and hypercholesterolaemia has also been studied extensively.Combination drug products occupy a time-honored and important role in therapeutics.The combination of Atorvastatin Calcium and Sildenafil is commercially available in tablet form to control erectile dysfunction.The Atorvastatin calcium and Sildenafil co-formulation, the IIEF-5 score was significantly decreased, maintaining cholesterol level.Analysis of samples with numerous components presents a major challenge in modern analysis.This article narrates different chromatographic (HPLC, HPTLC, UPLC, LC) & different spectrophotometric method (UV) for determination of the Atorvastatin Calcium and Sildenafil single drug as well as combination with other drug.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free